S-1 Impact 6/10 Ipo

$LIS · LIS Technologies Inc

November 18, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Amendment No. 2 to LIS Technologies' S-1 registers a firm-commitment IPO of 3,100,000 common shares at an assumed $6.00 midpoint ($5.00-$7.00 range), with a 30-day over-allotment option for 465,000 additional shares. The company has applied to list on Nasdaq under 'LIS' and has no prior public market. LIS is a pre-revenue, early-stage laser uranium enrichment company that has accumulated net losses of $65,418,743 from inception (Dec 31, 2021) through July 31, 2026.

  • Offering: 3,100,000 shares at $5.00-$7.00, assumed $6.00 midpoint, firm commitment.
  • Underwriting discount of 6.5% per share plus 1.15% non-accountable expense allowance.
  • Underwriters get warrants for 7% of shares sold at 115% of IPO price.
  • CEO Jay Jiang Yu and President Christo J. Liebenberg each indicated interest in buying up to $250,000 of shares.
  • No revenues to date; accumulated net losses of $65,418,743 through July 31, 2026.
PeriodInception (Dec 31, 2021) through July 31, 2026
Net income-$65,418,743

Price data unavailable.

A pre-revenue uranium enrichment startup is seeking a Nasdaq IPO to fund commercialization of its CRISLA laser technology amid a U.S. push to onshore nuclear fuel supply.

LIS positions itself as the only company with U.S.-origin patented laser uranium enrichment technology, targeting demand driven by the 2024 Prohibiting Russian Uranium Imports Act.

No revenues and $65.4M accumulated losses; commercial production requires NRC licenses not yet obtained. Nasdaq listing approval is not assured and is a condition to closing.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →